- Home
- GOSS vs LWAY Comparison
GOSS vs LWAY Comparison
Compare GOSS & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- LWAY
- Stock Information
- Founded
- GOSS 2015
- LWAY 1986
- Country
- GOSS United States
- LWAY United States
- Employees
- GOSS N/A
- LWAY N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- LWAY Packaged Foods
- Sector
- GOSS Health Care
- LWAY Consumer Staples
- Exchange
- GOSS Nasdaq
- LWAY Nasdaq
- Market Cap
- GOSS 501.2M
- LWAY 513.4M
- IPO Year
- GOSS 2019
- LWAY 1987
- Fundamental
- Price
- GOSS $3.17
- LWAY $22.21
- Analyst Decision
- GOSS Strong Buy
- LWAY Strong Buy
- Analyst Count
- GOSS 6
- LWAY 1
- Target Price
- GOSS $8.60
- LWAY $35.00
- AVG Volume (30 Days)
- GOSS 3.1M
- LWAY 91.9K
- Earning Date
- GOSS 11-05-2025
- LWAY 11-12-2025
- Dividend Yield
- GOSS N/A
- LWAY N/A
- EPS Growth
- GOSS N/A
- LWAY N/A
- EPS
- GOSS N/A
- LWAY 0.74
- Revenue
- GOSS $44,051,000.00
- LWAY $204,069,000.00
- Revenue This Year
- GOSS N/A
- LWAY $14.66
- Revenue Next Year
- GOSS $16.11
- LWAY $13.81
- P/E Ratio
- GOSS N/A
- LWAY $30.14
- Revenue Growth
- GOSS N/A
- LWAY 12.14
- 52 Week Low
- GOSS $0.66
- LWAY $19.50
- 52 Week High
- GOSS $3.60
- LWAY $34.20
- Technical
- Relative Strength Index (RSI)
- GOSS 68.68
- LWAY 32.70
- Support Level
- GOSS $2.42
- LWAY $20.96
- Resistance Level
- GOSS $2.71
- LWAY $26.99
- Average True Range (ATR)
- GOSS 0.19
- LWAY 1.59
- MACD
- GOSS 0.09
- LWAY -0.14
- Stochastic Oscillator
- GOSS 96.48
- LWAY 21.69
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About LWAY Lifeway Foods Inc.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.